{"transactions":[{"id":4622883,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-18T20:17:23.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":3674,"price":25.0009,"value":91853.3066,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2026, by the Reporting Person, with a plan end date of September 1, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.01, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":112508,"source":{"system":"sec-edgar","filing":"0001628280-26-062732","document":"wk-form4_1789762641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026062732/wk-form4_1789762641.xml","form_type":"4"}},{"id":4615245,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-10T23:24:41.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":9989,"price":25.0261,"value":249985.7129,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2026, by the Reporting Person, with a plan end date of September 1, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.12, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":116182,"source":{"system":"sec-edgar","filing":"0001628280-26-061444","document":"wk-form4_1789082678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026061444/wk-form4_1789082678.xml","form_type":"4"}},{"id":695796,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-06T01:42:17.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":1230,"price":26.1168,"value":32123.664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.72 to $26.69, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 712 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2026."}],"balance_after":126171,"source":{"system":"sec-edgar","filing":"0001628280-26-053754","document":"wk-form4_1785980535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026053754/wk-form4_1785980535.xml","form_type":"4"}},{"id":789998,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-06T23:40:04.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":884,"price":23.6106,"value":20871.7704,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.16 to $23.93, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":126689,"source":{"system":"sec-edgar","filing":"0001798679-26-000002","document":"wk-form4_1778110801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000179867926000002/wk-form4_1778110801.xml","form_type":"4"}},{"id":789997,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-06T23:40:04.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":7372,"price":23.2696,"value":171543.4912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.1167 to $23.48, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Due to a scrivener's error on the Reporting Person's Form 4 filed on March 3, 2026, the number of shares of common stock beneficially owned by the Reporting Person reflected a discrepancy that inadvertently overstated the Reporting Person's beneficial ownership by 1,987 shares. The correct number of shares beneficially owned by the Reporting Person is reflected in this Form 4."}],"balance_after":127573,"source":{"system":"sec-edgar","filing":"0001798679-26-000002","document":"wk-form4_1778110801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000179867926000002/wk-form4_1778110801.xml","form_type":"4"}},{"id":867769,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-04T01:42:21.000Z","date":"2026-02-27","kind":"grant","planned":true,"acquired":true,"shares":97000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":97000,"derivative":{"exercise_price":26.97,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":97000},"source":{"system":"sec-edgar","filing":"0001628280-26-014326","document":"wk-form4_1772588538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026014326/wk-form4_1772588538.xml","form_type":"4"}},{"id":867768,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:42:21.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":1987,"price":25.7,"value":51065.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."}],"balance_after":136932,"source":{"system":"sec-edgar","filing":"0001628280-26-014326","document":"wk-form4_1772588538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026014326/wk-form4_1772588538.xml","form_type":"4"}},{"id":867767,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:42:21.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":193,"price":25.9139,"value":5001.3827,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.71 to $26.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":136932,"source":{"system":"sec-edgar","filing":"0001628280-26-014326","document":"wk-form4_1772588538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026014326/wk-form4_1772588538.xml","form_type":"4"}},{"id":867766,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:42:21.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":6553,"price":25.1604,"value":164876.1012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.69 to $25.70, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":137125,"source":{"system":"sec-edgar","filing":"0001628280-26-014326","document":"wk-form4_1772588538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026014326/wk-form4_1772588538.xml","form_type":"4"}},{"id":867765,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:42:21.000Z","date":"2026-02-27","kind":"sale","planned":true,"acquired":false,"shares":3325,"price":27.95,"value":92933.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."}],"balance_after":143678,"source":{"system":"sec-edgar","filing":"0001628280-26-014326","document":"wk-form4_1772588538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026014326/wk-form4_1772588538.xml","form_type":"4"}},{"id":867764,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T01:42:21.000Z","date":"2026-02-27","kind":"grant","planned":true,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Constitute Restricted Stock Units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the \"Vesting Commencement Date\"), of each year beginning March 1, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":147003,"source":{"system":"sec-edgar","filing":"0001628280-26-014326","document":"wk-form4_1772588538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026014326/wk-form4_1772588538.xml","form_type":"4"}},{"id":919494,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-05T01:35:55.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":4714,"price":25.63,"value":120819.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.56 to $25.74, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":110003,"source":{"system":"sec-edgar","filing":"0001628280-26-005582","document":"wk-form4_1770255345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026005582/wk-form4_1770255345.xml","form_type":"4"}},{"id":919493,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-05T01:35:55.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":19379,"price":25.24,"value":489125.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.55 to $25.55, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":114717,"source":{"system":"sec-edgar","filing":"0001628280-26-005582","document":"wk-form4_1770255345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026005582/wk-form4_1770255345.xml","form_type":"4"}},{"id":919492,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-05T01:35:55.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":8562,"price":24.97,"value":213793.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.50 to $25.42, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":134096,"source":{"system":"sec-edgar","filing":"0001628280-26-005582","document":"wk-form4_1770255345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026005582/wk-form4_1770255345.xml","form_type":"4"}},{"id":919491,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-05T01:35:55.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":7983,"price":25.4984,"value":203553.7272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligation in connection with the vesting of Restricted Stock Units (\"RSUs\"), granted on January 12, 2024, in which 25% of the RSUs vest annually on February 1, (the \"Vesting Commencement Date\"), of each year beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.745 to $25.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":142658,"source":{"system":"sec-edgar","filing":"0001628280-26-005582","document":"wk-form4_1770255345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000162828026005582/wk-form4_1770255345.xml","form_type":"4"}},{"id":981662,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-03T22:24:39.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":1657,"price":30.23,"value":50091.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 822 shares acquired under Arcutis Biotherapeutics, Inc. Employee Stock Purchase Plan on November 30, 2025."}],"balance_after":150641,"source":{"system":"sec-edgar","filing":"0001798679-25-000007","document":"wk-form4_1764800677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000179867925000007/wk-form4_1764800677.xml","form_type":"4"}},{"id":991438,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-21T23:34:04.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":1561,"price":28.5,"value":44488.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.24 to $28.95, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":151476,"source":{"system":"sec-edgar","filing":"0001798679-25-000006","document":"wk-form4_1763768041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000179867925000006/wk-form4_1763768041.xml","form_type":"4"}},{"id":991437,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-21T23:34:04.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":989,"price":27.9541,"value":27646.6049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $27.21 to $28.21, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":153037,"source":{"system":"sec-edgar","filing":"0001798679-25-000006","document":"wk-form4_1763768041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000179867925000006/wk-form4_1763768041.xml","form_type":"4"}},{"id":1006870,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-05T23:23:52.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":43,"price":25.3985,"value":1092.1355,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.3361 to $25.40, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":154026,"source":{"system":"sec-edgar","filing":"0001798679-25-000004","document":"wk-form4_1762385030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000179867925000004/wk-form4_1762385030.xml","form_type":"4"}},{"id":1006869,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-05T23:23:52.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":7165,"price":24.7123,"value":177063.6295,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.31 to $25.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":154069,"source":{"system":"sec-edgar","filing":"0001798679-25-000004","document":"wk-form4_1762385030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000179867925000004/wk-form4_1762385030.xml","form_type":"4"}},{"id":1045918,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-08T21:14:39.000Z","date":"2025-09-04","kind":"sale","planned":true,"acquired":false,"shares":36130,"price":16.156,"value":583716.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.93 to $16.3787, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":161234,"source":{"system":"sec-edgar","filing":"0001787306-25-000134","document":"wk-form4_1757366076.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730625000134/wk-form4_1757366076.xml","form_type":"4"}},{"id":1074677,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T22:28:45.000Z","date":"2025-08-04","kind":"sale","planned":true,"acquired":false,"shares":6330,"price":14.3266,"value":90687.378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.965 to $14.675, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,095 shares purchased  under the Issuer's Employee Stock Purchase Plan on May 31, 2025."}],"balance_after":197364,"source":{"system":"sec-edgar","filing":"0001787306-25-000116","document":"wk-form4_1754432921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730625000116/wk-form4_1754432921.xml","form_type":"4"}},{"id":1130597,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-30T00:25:43.000Z","date":"2025-05-28","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":13.7814,"value":24806.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (\"PSUs\"), granted on January 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.64 to $14.16, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":202599,"source":{"system":"sec-edgar","filing":"0002065881-25-000011","document":"wk-form4_1748564737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000206588125000011/wk-form4_1748564737.xml","form_type":"4"}},{"id":1159364,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-05T21:20:36.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":5030,"price":15.1995,"value":76453.485,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted on February 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.75 to $15.57, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":204399,"source":{"system":"sec-edgar","filing":"0001787306-25-000086","document":"wk-form4_1746480029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730625000086/wk-form4_1746480029.xml","form_type":"4"}},{"id":1228985,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-05T00:43:09.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":89000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":89000,"derivative":{"exercise_price":13.69,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":89000},"source":{"system":"sec-edgar","filing":"0001787306-25-000038","document":"wk-form4_1741135382.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730625000038/wk-form4_1741135382.xml","form_type":"4"}},{"id":1228984,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T00:43:09.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":3263,"price":13.0311,"value":42520.4793,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, granted on March 3, 2022 and March 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.6902 to $13.83, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":209429,"source":{"system":"sec-edgar","filing":"0001787306-25-000038","document":"wk-form4_1741135382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730625000038/wk-form4_1741135382.xml","form_type":"4"}},{"id":1228983,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T00:43:09.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the \"Vesting Commencement Date\"), of each year beginning March 1, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":212692,"source":{"system":"sec-edgar","filing":"0001787306-25-000038","document":"wk-form4_1741135382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730625000038/wk-form4_1741135382.xml","form_type":"4"}},{"id":1285012,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-05T01:01:19.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":8338,"price":12.7,"value":105892.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\"), granted on January 12, 2024, in which 25% of the RSUs vest annually on February 1, (the \"Vesting Commencement Date\"), of each year beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.545 to $13.0096, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the adjusted total which includes the acquisition of 4,000 shares and 1,657 shares under the Company's Employee Stock Purchase Plan on May 31, 2024 and November 30, 2024, respectively, which transactions were exempt from Section 16(a) and (b) and were erroneously reported as non-exempt purchases in the Reporting Person's Form 4 filed on December 3, 2024."}],"balance_after":178692,"source":{"system":"sec-edgar","filing":"0001787306-25-000017","document":"wk-form4_1738717273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730625000017/wk-form4_1738717273.xml","form_type":"4"}},{"id":1345190,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-12-03T21:16:58.000Z","date":"2024-11-30","kind":"purchase","planned":false,"acquired":true,"shares":1657,"price":7.106,"value":11774.642,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the purchase transaction of the Company's Employee Stock Purchase Plan."}],"balance_after":187030,"source":{"system":"sec-edgar","filing":"0001787306-24-000168","document":"wk-form4_1733260612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000168/wk-form4_1733260612.xml","form_type":"4"}},{"id":1345189,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-12-03T21:16:58.000Z","date":"2024-05-31","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":1.692,"value":6768.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the purchase transaction of the Company's Employee Stock Purchase Plan."}],"balance_after":185373,"source":{"system":"sec-edgar","filing":"0001787306-24-000168","document":"wk-form4_1733260612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000168/wk-form4_1733260612.xml","form_type":"4"}},{"id":1359349,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-20T00:52:52.000Z","date":"2024-11-19","kind":"sale","planned":true,"acquired":false,"shares":1775,"price":9.6847,"value":17190.3425,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable tax withholdings."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.22 to $10.09, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":181373,"source":{"system":"sec-edgar","filing":"0001787306-24-000159","document":"wk-form4_1732063965.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000159/wk-form4_1732063965.xml","form_type":"4"}},{"id":1359348,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-20T00:52:52.000Z","date":"2024-11-18","kind":"grant","planned":true,"acquired":true,"shares":4875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units (\"PSUs\") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was  certified as satisfied on November 18, 2022. The PSUs vest 25% per year on each anniversary of the certification date,  subject to the Reporting Person's continued service to the Issuer on such vesting date."}],"balance_after":183148,"source":{"system":"sec-edgar","filing":"0001787306-24-000159","document":"wk-form4_1732063965.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000159/wk-form4_1732063965.xml","form_type":"4"}},{"id":1375559,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:46:25.000Z","date":"2024-11-04","kind":"sale","planned":true,"acquired":false,"shares":5015,"price":8.6842,"value":43551.263,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to the Issuer's mandatory sell-to-cover requirements implemented to satisfy the tax withholding obligations associated with the vesting of the Reporting Person's Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $8.32 to $8.86, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":178273,"source":{"system":"sec-edgar","filing":"0001787306-24-000145","document":"wk-form4_1730843178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000145/wk-form4_1730843178.xml","form_type":"4"}},{"id":1440828,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-05T20:37:37.000Z","date":"2024-08-02","kind":"sale","planned":true,"acquired":false,"shares":5220,"price":9.0161,"value":47064.042,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in  connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $8.74 to $9.26, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":183288,"source":{"system":"sec-edgar","filing":"0001787306-24-000118","document":"wk-form4_1722890249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000118/wk-form4_1722890249.xml","form_type":"4"}},{"id":1499232,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2024-05-29T23:38:07.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":1775,"price":9.0074,"value":15988.135,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was made pursuant to the Issuer's mandatory sell-to-cover requirements implemented to satisfy the tax withholding obligations associated with the vesting of the reporting person's PSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $8.99 to $9.02, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":188508,"source":{"system":"sec-edgar","filing":"0001787306-24-000083","document":"wk-form4_1717025879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000083/wk-form4_1717025879.xml","form_type":"4"}},{"id":1499231,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2024-05-29T23:38:07.000Z","date":"2024-05-27","kind":"grant","planned":true,"acquired":true,"shares":4875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units (\"PSUs\") initially granted on January 3, 2022 that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on May 27, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date."}],"balance_after":190283,"source":{"system":"sec-edgar","filing":"0001787306-24-000083","document":"wk-form4_1717025879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000083/wk-form4_1717025879.xml","form_type":"4"}},{"id":1528443,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2024-05-03T20:22:39.000Z","date":"2024-05-02","kind":"sale","planned":true,"acquired":false,"shares":5016,"price":8.7378,"value":43828.8048,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $8.47 to $9.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":185408,"source":{"system":"sec-edgar","filing":"0001787306-24-000069","document":"wk-form4_1714767741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000069/wk-form4_1714767741.xml","form_type":"4"}},{"id":1591905,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2024-03-06T22:14:54.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":3760,"price":11.1212,"value":41815.712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $11.000 to $11.3200, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":190424,"source":{"system":"sec-edgar","filing":"0001787306-24-000042","document":"wk-form4_1709763281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000042/wk-form4_1709763281.xml","form_type":"4"}},{"id":1641111,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:32:32.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 2, 2023. and received in exchange for the option, these RSUs that vest in twelve equal quarterly installments commencing May 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The canceled option vest as to 1/48 of the shares subject to the option vest on each monthly anniversary measured from March 1, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":0,"derivative":{"exercise_price":15.82,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":55800},"source":{"system":"sec-edgar","filing":"0001787306-24-000018","document":"wk-form4_1708039941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000018/wk-form4_1708039941.xml","form_type":"4"}},{"id":1641110,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:32:32.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2022,  and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The canceled option vest as to 1/48 of the shares subject to the option vest on each monthly anniversary measured from March 1, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":0,"derivative":{"exercise_price":17.67,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":35300},"source":{"system":"sec-edgar","filing":"0001787306-24-000018","document":"wk-form4_1708039941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000018/wk-form4_1708039941.xml","form_type":"4"}},{"id":1641109,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:32:32.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":185000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on January 3, 2022, and received in exchange for the option, these Restricted Stock Units (\"RSUs\") that vest in eight equal quarterly installments commencing May 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The canceled option vested as to 1/4 of the total shares on January 3, 2023, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vesting on January 3, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":22.79,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001787306-24-000018","document":"wk-form4_1708039941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000018/wk-form4_1708039941.xml","form_type":"4"}},{"id":1641108,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2024-02-15T23:32:32.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":27900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 2, 2023. and received in exchange for the option, these RSUs that vest in twelve equal quarterly installments commencing May 1, 2024."}],"balance_after":194184,"source":{"system":"sec-edgar","filing":"0001787306-24-000018","document":"wk-form4_1708039941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000018/wk-form4_1708039941.xml","form_type":"4"}},{"id":1641107,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2024-02-15T23:32:32.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":17650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2022,  and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024."}],"balance_after":166284,"source":{"system":"sec-edgar","filing":"0001787306-24-000018","document":"wk-form4_1708039941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000018/wk-form4_1708039941.xml","form_type":"4"}},{"id":1641106,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2024-02-15T23:32:32.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":74000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on January 3, 2022, and received in exchange for the option, these Restricted Stock Units (\"RSUs\") that vest in eight equal quarterly installments commencing May 1, 2024."}],"balance_after":148634,"source":{"system":"sec-edgar","filing":"0001787306-24-000018","document":"wk-form4_1708039941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000018/wk-form4_1708039941.xml","form_type":"4"}},{"id":1677988,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-17T21:32:50.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniverary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":176000,"derivative":{"exercise_price":3.64,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0001787306-24-000008","document":"wk-form4_1705527155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000008/wk-form4_1705527155.xml","form_type":"4"}},{"id":1677987,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2024-01-17T21:32:50.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute Restricted Stock Units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting.  25% of the RSUs vest annual on February 1, (the \"Vesting Commencement Date\"), of each year, beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":74634,"source":{"system":"sec-edgar","filing":"0001787306-24-000008","document":"wk-form4_1705527155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730624000008/wk-form4_1705527155.xml","form_type":"4"}},{"id":1732805,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2023-11-21T22:47:43.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":1850,"price":1.979,"value":3661.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable tax withholdings."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trade in prices ranging from $1.965 to $1.98, inclusive. The price reported in Column 4 reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":46634,"source":{"system":"sec-edgar","filing":"0001787306-23-000126","document":"wk-form4_1700606852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730623000126/wk-form4_1700606852.xml","form_type":"4"}},{"id":1732804,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2023-11-21T22:47:43.000Z","date":"2023-11-18","kind":"grant","planned":false,"acquired":true,"shares":4875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units (\"PSUs\") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on November 18, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date."}],"balance_after":48484,"source":{"system":"sec-edgar","filing":"0001787306-23-000126","document":"wk-form4_1700606852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730623000126/wk-form4_1700606852.xml","form_type":"4"}},{"id":1870141,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2023-06-03T00:31:18.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":1463,"price":6.38,"value":9333.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":43609,"source":{"system":"sec-edgar","filing":"0001787306-23-000066","document":"wk-form4_1685752267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730623000066/wk-form4_1685752267.xml","form_type":"4"}},{"id":1870140,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2023-06-03T00:31:18.000Z","date":"2023-05-31","kind":"sale","planned":false,"acquired":false,"shares":1830,"price":7.8023,"value":14278.209,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs,  the shares were sold upon the vesting of the PSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $7.79 to $7.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":42146,"source":{"system":"sec-edgar","filing":"0001787306-23-000066","document":"wk-form4_1685752267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730623000066/wk-form4_1685752267.xml","form_type":"4"}},{"id":1870139,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2023-06-03T00:31:18.000Z","date":"2023-05-27","kind":"grant","planned":false,"acquired":true,"shares":4875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Performance Stock Units (\"PSUs\") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on May 27, 2022.  The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date."}],"balance_after":43976,"source":{"system":"sec-edgar","filing":"0001787306-23-000066","document":"wk-form4_1685752267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730623000066/wk-form4_1685752267.xml","form_type":"4"}},{"id":1969272,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T23:52:55.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":55800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 2, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":55800,"derivative":{"exercise_price":15.82,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":55800},"source":{"system":"sec-edgar","filing":"0001567619-23-004542","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761923004542/doc1.xml","form_type":"4"}},{"id":1969271,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-06T23:52:55.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 2 of each year, beginning March 2, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":39101,"source":{"system":"sec-edgar","filing":"0001567619-23-004542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761923004542/doc1.xml","form_type":"4"}},{"id":1969270,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-06T23:52:55.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":18,"price":16.52,"value":297.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":18101,"source":{"system":"sec-edgar","filing":"0001567619-23-004542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761923004542/doc1.xml","form_type":"4"}},{"id":1969269,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-06T23:52:55.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":1416,"price":15.8181,"value":22398.4296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $15.470 to $16.460, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":18119,"source":{"system":"sec-edgar","filing":"0001567619-23-004542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761923004542/doc1.xml","form_type":"4"}},{"id":2107024,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2022-11-23T00:06:14.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":1720,"price":18.1912,"value":31288.864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,300 Restricted Stock Units (\"RSUs\")."}],"balance_after":19535,"source":{"system":"sec-edgar","filing":"0001787306-22-000077","document":"wf-form4_166916195632010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730622000077/wf-form4_166916195632010.xml","form_type":"4"}},{"id":2107023,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Common Stock","published_at":"2022-11-23T00:06:14.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":4875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units (\"PSUs\") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on November 18, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,300 Restricted Stock Units (\"RSUs\")."}],"balance_after":21255,"source":{"system":"sec-edgar","filing":"0001787306-22-000077","document":"wf-form4_166916195632010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000178730622000077/wf-form4_166916195632010.xml","form_type":"4"}},{"id":2247714,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-06-02T20:48:55.000Z","date":"2022-06-02","kind":"sale","acquired":false,"shares":1795,"price":19.7318,"value":35418.581,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $19.7201 to $19.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,300 RSUs."}],"balance_after":16380,"source":{"system":"sec-edgar","filing":"0001567619-22-012149","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761922012149/doc1.xml","form_type":"4"}},{"id":2247713,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-06-02T20:48:55.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":4875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units (\"PSUs\") initially granted on January 3, 2022 that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on May 27, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,300 RSUs."}],"balance_after":18175,"source":{"system":"sec-edgar","filing":"0001567619-22-012149","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761922012149/doc1.xml","form_type":"4"}},{"id":2348108,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T01:52:09.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":35300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 3, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":35300,"derivative":{"exercise_price":17.67,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":35300},"source":{"system":"sec-edgar","filing":"0001567619-22-006496","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761922006496/doc1.xml","form_type":"4"}},{"id":2348107,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-03-08T01:52:09.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 3 of each year, beginning March 3, 2023, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,300 RSUs."}],"balance_after":13300,"source":{"system":"sec-edgar","filing":"0001567619-22-006496","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761922006496/doc1.xml","form_type":"4"}},{"id":2444272,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T00:43:03.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the one year anniversary measured from January 3, 2022 (the \"Vesting Commencement Date\"), and 1/48th of the shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":185000,"derivative":{"exercise_price":22.79,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001567619-22-000671","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798679/000156761922000671/doc1.xml","form_type":"4"}},{"id":2577542,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-09-07T21:42:24.000Z","date":"2021-09-04","kind":"exercise","acquired":false,"shares":6883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":6883,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6883},"source":{"system":"sec-edgar","filing":"0001179110-21-008662","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021008662/edgar.xml","form_type":"4"}},{"id":2577541,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-09-07T21:42:24.000Z","date":"2021-09-04","kind":"tax_withholding","acquired":false,"shares":3412,"price":42.22,"value":144054.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 3,412 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":20049,"source":{"system":"sec-edgar","filing":"0001179110-21-008662","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021008662/edgar.xml","form_type":"4"}},{"id":2577540,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-09-07T21:42:24.000Z","date":"2021-09-04","kind":"exercise","acquired":true,"shares":6883,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23461,"source":{"system":"sec-edgar","filing":"0001179110-21-008662","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021008662/edgar.xml","form_type":"4"}},{"id":2855389,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-02-17T22:05:57.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":13544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."}],"balance_after":13544,"derivative":{"exercise_price":0,"exercise_date":"2022-02-15","underlying":"Common Stock","underlying_shares":13544},"source":{"system":"sec-edgar","filing":"0001179110-21-001811","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001811/edgar.xml","form_type":"4"}},{"id":2855388,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Option to Purchase Common Stock","published_at":"2021-02-17T22:05:57.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":23311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and then 1/48th monthly thereafter."}],"balance_after":23311,"derivative":{"exercise_price":49.84,"exercise_date":"2022-02-15","expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":23311},"source":{"system":"sec-edgar","filing":"0001179110-21-001811","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001811/edgar.xml","form_type":"4"}},{"id":2863945,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Restricted Stock","published_at":"2021-02-13T00:10:11.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":4129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":8258,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4129},"source":{"system":"sec-edgar","filing":"0001179110-21-001653","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001653/edgar.xml","form_type":"4"}},{"id":2863944,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-02-13T00:10:11.000Z","date":"2021-02-10","kind":"exercise","acquired":false,"shares":6257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":18769,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6257},"source":{"system":"sec-edgar","filing":"0001179110-21-001653","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001653/edgar.xml","form_type":"4"}},{"id":2863943,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-02-13T00:10:11.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":2047,"price":49.84,"value":102022.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported disposition of 2,047 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":16578,"source":{"system":"sec-edgar","filing":"0001179110-21-001653","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001653/edgar.xml","form_type":"4"}},{"id":2863942,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-02-13T00:10:11.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":4129,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18625,"source":{"system":"sec-edgar","filing":"0001179110-21-001653","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001653/edgar.xml","form_type":"4"}},{"id":2863941,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-02-13T00:10:11.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":3203,"price":50.6,"value":162071.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 3,203 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":14496,"source":{"system":"sec-edgar","filing":"0001179110-21-001653","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001653/edgar.xml","form_type":"4"}},{"id":2863940,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-02-13T00:10:11.000Z","date":"2021-02-10","kind":"exercise","acquired":true,"shares":6257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17699,"source":{"system":"sec-edgar","filing":"0001179110-21-001653","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001653/edgar.xml","form_type":"4"}},{"id":3037875,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-09-04T22:13:40.000Z","date":"2020-09-04","kind":"exercise","acquired":false,"shares":6884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":13766,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6884},"source":{"system":"sec-edgar","filing":"0001179110-20-009605","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020009605/edgar.xml","form_type":"4"}},{"id":3037874,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-09-04T22:13:40.000Z","date":"2020-09-04","kind":"tax_withholding","acquired":false,"shares":2380,"price":27.7,"value":65926.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 2,380 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":11442,"source":{"system":"sec-edgar","filing":"0001179110-20-009605","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020009605/edgar.xml","form_type":"4"}},{"id":3037873,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-09-04T22:13:40.000Z","date":"2020-09-04","kind":"exercise","acquired":true,"shares":6884,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13822,"source":{"system":"sec-edgar","filing":"0001179110-20-009605","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020009605/edgar.xml","form_type":"4"}},{"id":3274502,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-02-13T23:41:04.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":4130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":12387,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4130},"source":{"system":"sec-edgar","filing":"0001179110-20-001583","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020001583/edgar.xml","form_type":"4"}},{"id":3274501,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-02-13T23:41:04.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":1681,"price":20,"value":33620.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 1,681 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":6938,"source":{"system":"sec-edgar","filing":"0001179110-20-001583","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020001583/edgar.xml","form_type":"4"}},{"id":3274500,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-02-13T23:41:04.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":4130,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8619,"source":{"system":"sec-edgar","filing":"0001179110-20-001583","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020001583/edgar.xml","form_type":"4"}},{"id":3277500,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-02-12T23:05:16.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":25026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."}],"balance_after":25026,"derivative":{"exercise_price":0,"exercise_date":"2021-02-10","underlying":"Common Stock","underlying_shares":25026},"source":{"system":"sec-edgar","filing":"0001179110-20-001536","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020001536/edgar.xml","form_type":"4"}},{"id":3277499,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":26254,"kind":"person","name":"Matsuda Masaru","position":1,"cik":"0001798679","reported_name":"Matsuda Masaru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Option to Purchase Common Stock","published_at":"2020-02-12T23:05:16.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":53211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and then 1/48th monthly thereafter."}],"balance_after":53211,"derivative":{"exercise_price":19.98,"exercise_date":"2021-02-10","expiration_date":"2030-02-10","underlying":"Common Stock","underlying_shares":53211},"source":{"system":"sec-edgar","filing":"0001179110-20-001536","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020001536/edgar.xml","form_type":"4"}}]}